Dopamine Hydrochloride 98%
8 Inquiries
62-31-7
Pharmaceutical Grade
98%
TIANJIN
10kg/Cardboard Drum
2020-01-27
Nicotinamide,Paracetamol,R-Tetrahydropapaverine N-acetyl-L-leucinate R-,Clopidogrel Bisulfate,Cisatracurium Besilate,Dopamine Hydrochloride
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
Dopamine hydrochloride
Other Name:1,2-Benzenediol,4-(2-aminoethyl)-,hydrochloride (1:1);Pyrocatechol,4-(2-aminoethyl)-,hydrochloride;1,2-Benzenediol,4-(2-aminoethyl)-,hydrochloride;Dopamine hydrochloride;3-Hydroxytyramine hydrochloride;β-(3,4-Dihydroxyphenyl)ethylamine hydrochloride;3,4-Dihydroxyphenethylamine hydrochloride;Intropin;Dopamine chloride;m-Hydroxytyramine hydrochloride;P 498;2-(3,4-Dihydroxyphenyl)ethylamine hydrochloride;KW 3160;Inovan;Revivan;3,4-Dihydroxy-β-phenethylamine hydrochloride;Tensamin;Rascordin;Dynatra;Cardiosteril;Inotropin;Dopastat;ASL 279;Dopamine Fresenius;Dopamine Pierre Faba;4-(2-Aminoethyl)-1,2-benzenediol hydrochloride;Dopadic;Dopmin;2-(3,4-Dihydroxyphenyl)ethanaminium chloride;H 8502;1477-71-0;2002410-63-9
CAS No.:62-31-7
Molecular Formula:C8H11NO2.ClH
InChIKeys:InChIKey=CTENFNNZBMHDDG-UHFFFAOYSA-N
Molecular Weight:189.64
Exact Mass:189.055649
BRN:3656720
EC Number:200-527-8
UNII:7L3E358N9L
NSC Number:756749|169105
DSSTox ID:DTXSID7020550
NCI Thesaurus Code:C455
HScode:29222900
Categories:
Characteristics-
PSA:
66.5
XLogP3:2.10130
Appearance:light tan Crystalline Powder
Density:1.4 g/cm3
Melting Point:220 °C (decomp) @ Solvent: Water
Boiling Point:337.7ºC at 760 mmHg
Flash Point:11℃
Water Solubility:alcohol: 20 mg/mL
Storage Conditions:Store at -20°C
Toxicity:Oral-Rat LD50 2859 mg/kg; Oral-Mouse LD50: 4361 mg/kg
Flammability characteristics:Flammable, decomposes toxic nitrogen oxides and chloride gases when burned
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 4, Oral
Hazardous to the aquatic environment, short-term (Acute) - Category Acute 1
Hazardous to the aquatic environment, long-term (Chronic) - Category Chronic 1
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Warning
Hazard statement(s) H302 Harmful if swallowed
H410 Very toxic to aquatic life with long lasting effects
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P273 Avoid release to the environment.
Response P301+P317 IF SWALLOWED: Get medical help.
P330 Rinse mouth.
P391 Collect spillage.
Storage none
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Nicotinamide,Paracetamol,R-Tetrahydropapaverine N-acetyl-L-leucinate R-,Clopidogrel Bisulfate,Cisatracurium Besilate,Dopamine Hydrochloride
-
Location:
Chengguan Town, Wuqing District, Tianjin Province, China
-
Payment Terms:
TT against copy of documents,O/A
-
Average lead Time:
10
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
101-200
-
Year of Establishment:
2004
-
Certifications:
China Great Wall (Tianjin) Quality Assurance Center Environment Management System Certification,HALAL,KOSHER,GMP,GMP,GMP,GMP
Tianjin Zhongrui Pharmaceutical co., Ltd. is a professional productive enterprise which dedicates to manufacture pharmaceutical ingredients and intermediates, and established in 2004 with total registered capital of CNY 26 million. The legal representative is Liu Changsuo and chief founders are natural persons from Beijing. Company’s main products include Niacin, Niacinamide , Inositol Nicotinate, Terazosin Hcl, Amifostine, Strontium Renalate, Cisatracurium Besilate, Fasudil Hcl, Clopidogrel hydrogen sulfate, Dopamine Hcl, Febuxostat, etc.
Tianjin Zhongrui serves as an integrated pharmaceutical manufacturer, owning advanced production equipments, "GMP" workshops, and various sophisticated testing instruments. Most company leadership team members are professional and technical with rich experience in pharmaceutical, gaining college degree or above education. The site covers a total area of 21000㎡, of which production workshops 1656 ㎡, QC laboratory 360㎡. Production lines of all raw materials are equipped with special equipments and independent air conditioning system. Our quality control capability is qualified to the production scale. All products pass the GMP certification. Our facility conditions conform to the requirements of the technology, production safety, environmental protection. Internal research institute is equipped with advanced R&D equipments and pilot plant.
Tianijn Zhongrui relies on strong technical force, high-quality work team, perfect quality assurance system to build ourselves as a high-tech enterprise. Therefor the company has achieved rapidly development.
In 2009, Tianjin Zhongrui was identified as high-tech enterprises, and passed the reexamination in 2012. New production technology of Nicotinamide was incorporated into science and technology innovation projects of Tianjin Science and Technology Commission. Strontium Ranelate gets supported by “technology personnel service enterprise action” project of Ministry of Science. The company spent more than CNY3 million on R&D in 2012.
In 2009, in order to introduce the advanced production technology of new drugs and pursue the better development, Tianjin Zhongrui cooperated with a technology-based private institute from Beijing, which is specialized in new drug research and development. This institute invested six new drug’s research achievements and CNY6 million to Tianjin Zhongrui, which injected a huge fresh vitality of science and technology.
-
-
Inquiry History8 Inquiries
Country Product Purchase Quantity Date Posted 
Saudi Arabia
dispex aa4040
5000 KG Jan 5, 2026 
United States
3-hydroxytyramine
1 KG Nov 10, 2024 
Pakistan
Dopamine Hydrochloride
1 KG Nov 1, 2024 
Canada
Dopamine HCl
25 KG Feb 7, 2024 
New Zealand
dopamine hydrochloride
1 MT Nov 28, 2024
United States
Dopamine Hydrochloride
25 KG Nov 9, 2024 
France
Dopamine HCl
250 KG Oct 4, 2024
United States
3-hydroxytyramine
1 KG Nov 9, 2024 Post an enquiry for this product
Hot Related Products
-
![10597-60-1,3,4-Dihydroxyphenylethanol,99,Hydroxytyrosol, 3,4-Dihydroxyphenylethanol, 4-(2-Hydroxyethyl)benzene-1,2-diol, Dopaol]( "10597-60-1,3,4-Dihydroxyphenylethanol,99,Hydroxytyrosol, 3,4-Dihydroxyphenylethanol, 4-(2-Hydroxyethyl)benzene-1,2-diol, Dopaol")
10597-60-1,3,4-Dihydroxyphenylethanol,99,Hydroxytyrosol, 3,4-Dihydroxyphenylethanol, 4-(2-Hydroxyethyl)benzene-1,2-diol, Dopaol -
![Hydroxytyrosol ,Olive Leaf extract 99%]( "Hydroxytyrosol ,Olive Leaf extract 99%")
Hydroxytyrosol ,Olive Leaf extract 99%$33-38.5/G FOB
-
![Hydroxytyrosol 99% White or of- white powder or crystlline power]( "Hydroxytyrosol 99% White or of- white powder or crystlline power")
Hydroxytyrosol 99% White or of- white powder or crystlline power -
![Viablife Hydroxytyrosol-Pharmaceutice Intemediates Powder Sam]( "Viablife Hydroxytyrosol-Pharmaceutice Intemediates Powder Sam")
Viablife Hydroxytyrosol-Pharmaceutice Intemediates Powder Sam -
![CAS 102-32-9 3,4-Dihydroxybenzeneacetic Acid]( "CAS 102-32-9 3,4-Dihydroxybenzeneacetic Acid")
CAS 102-32-9 3,4-Dihydroxybenzeneacetic Acid -
![3,4-Dihydroxyphenylacetic acid-chemtour]( "3,4-Dihydroxyphenylacetic acid-chemtour")
3,4-Dihydroxyphenylacetic acid-chemtour
